Ireland based, US stock market listed, Icon PLC has been accused of engaging in a “scheme to deceive the market” as a huge US pension fund filed a legal class action against the clinical trials ...

Choose from Clinical Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

The upcoming 15th Annual Outsourcing in Clinical Trials Europe conference will cover a wide range of topics on clinical ...

HepaRegeniX is backed by experienced life science investors, including Vesalius Biocapital IV, Novo Holdings A/S, Boehringer Ingelheim Venture Fund (BIVF), Coparion, High-Tech Gründerfonds, Ascenion ...

We are thrilled to welcome Jessica to the RAPT leadership team at this pivotal time for the company,” said Brian Wong, M.D., Ph.D., President and CEO of RAPT. “With her deep expertise as both an ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...

The vaccine helps the body recognise, attack and “remember” cancer cells to help stop the disease from returning. | ITV News ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

Avidity's delpacibart etedesiran (del-desiran) was granted orphan drug status in Japan as a treatment for myotonic dystrophy type 1 (DM1).